These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 26928845

  • 1. Effects of testosterone replacement on metabolic and inflammatory markers in men with opioid-induced androgen deficiency.
    Huang G, Travison T, Maggio M, Edwards RR, Basaria S.
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):232-8. PubMed ID: 26928845
    [Abstract] [Full Text] [Related]

  • 2. Effects of Testosterone Replacement on Pain Catastrophizing and Sleep Quality in Men with Opioid-Induced Androgen Deficiency.
    Huang G, Travison TG, Edwards RR, Basaria S.
    Pain Med; 2017 Jun 01; 18(6):1070-1076. PubMed ID: 27550959
    [Abstract] [Full Text] [Related]

  • 3. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial.
    Basaria S, Travison TG, Alford D, Knapp PE, Teeter K, Cahalan C, Eder R, Lakshman K, Bachman E, Mensing G, Martel MO, Le D, Stroh H, Bhasin S, Wasan AD, Edwards RR.
    Pain; 2015 Feb 01; 156(2):280-288. PubMed ID: 25599449
    [Abstract] [Full Text] [Related]

  • 4. Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency.
    Eichenbaum G, Göhler K, Etropolski M, Steigerwald I, Pergolizzi J, Kim M, Vorsanger G.
    J Opioid Manag; 2015 Feb 01; 11(3):211-27. PubMed ID: 25985806
    [Abstract] [Full Text] [Related]

  • 5. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
    Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI.
    J Clin Endocrinol Metab; 2008 Jan 01; 93(1):139-46. PubMed ID: 17940111
    [Abstract] [Full Text] [Related]

  • 6. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency.
    Daniell HW, Lentz R, Mazer NA.
    J Pain; 2006 Mar 01; 7(3):200-10. PubMed ID: 16516826
    [Abstract] [Full Text] [Related]

  • 7. Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study.
    Piltonen T, Puurunen J, Hedberg P, Ruokonen A, Mutt SJ, Herzig KH, Nissinen A, Morin-Papunen L, Tapanainen JS.
    Hum Reprod; 2012 Oct 01; 27(10):3046-56. PubMed ID: 22811306
    [Abstract] [Full Text] [Related]

  • 8. Prospective study of effect of androgens on serum inflammatory markers in men.
    Ng MK, Liu PY, Williams AJ, Nakhla S, Ly LP, Handelsman DJ, Celermajer DS.
    Arterioscler Thromb Vasc Biol; 2002 Jul 01; 22(7):1136-41. PubMed ID: 12117728
    [Abstract] [Full Text] [Related]

  • 9. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P, Saghir A, Blast Study Group.
    Int J Clin Pract; 2014 Feb 01; 68(2):203-15. PubMed ID: 24355040
    [Abstract] [Full Text] [Related]

  • 10. Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease.
    Brockenbrough AT, Dittrich MO, Page ST, Smith T, Stivelman JC, Bremner WJ.
    Am J Kidney Dis; 2006 Feb 01; 47(2):251-62. PubMed ID: 16431254
    [Abstract] [Full Text] [Related]

  • 11. The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance.
    Friedl KE, Jones RE, Hannan CJ, Plymate SR.
    J Clin Endocrinol Metab; 1989 May 01; 68(5):971-5. PubMed ID: 2654171
    [Abstract] [Full Text] [Related]

  • 12. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
    Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL, Grobbee DE, van der Schouw YT.
    JAMA; 2008 Jan 02; 299(1):39-52. PubMed ID: 18167405
    [Abstract] [Full Text] [Related]

  • 13. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial.
    Ng Tang Fui M, Hoermann R, Prendergast LA, Zajac JD, Grossmann M.
    Int J Obes (Lond); 2017 Mar 02; 41(3):420-426. PubMed ID: 28028318
    [Abstract] [Full Text] [Related]

  • 14. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study.
    Miller KK, Biller BM, Beauregard C, Lipman JG, Jones J, Schoenfeld D, Sherman JC, Swearingen B, Loeffler J, Klibanski A.
    J Clin Endocrinol Metab; 2006 May 02; 91(5):1683-90. PubMed ID: 16478814
    [Abstract] [Full Text] [Related]

  • 15. Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial.
    Huang G, Tang E, Aakil A, Anderson S, Jara H, Davda M, Stroh H, Travison TG, Bhasin S, Basaria S.
    J Clin Endocrinol Metab; 2014 Jul 02; 99(7):E1287-93. PubMed ID: 24712568
    [Abstract] [Full Text] [Related]

  • 16. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
    Boyanov MA, Boneva Z, Christov VG.
    Aging Male; 2003 Mar 02; 6(1):1-7. PubMed ID: 12809074
    [Abstract] [Full Text] [Related]

  • 17. Short-Term Estrogen Withdrawal Increases Adiposity in Healthy Men.
    Chao J, Rubinow KB, Kratz M, Amory JK, Matsumoto AM, Page ST.
    J Clin Endocrinol Metab; 2016 Oct 02; 101(10):3724-3731. PubMed ID: 27482750
    [Abstract] [Full Text] [Related]

  • 18. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial.
    Spitzer M, Basaria S, Travison TG, Davda MN, Paley A, Cohen B, Mazer NA, Knapp PE, Hanka S, Lakshman KM, Ulloor J, Zhang A, Orwoll K, Eder R, Collins L, Mohammed N, Rosen RC, DeRogatis L, Bhasin S.
    Ann Intern Med; 2012 Nov 20; 157(10):681-91. PubMed ID: 23165659
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up.
    Behre HM, Tammela TL, Arver S, Tolrá JR, Bonifacio V, Lamche M, Kelly J, Hiemeyer F, European Testogel® Study Team, Giltay EJ, Gooren LJ.
    Aging Male; 2012 Dec 20; 15(4):198-207. PubMed ID: 22834649
    [Abstract] [Full Text] [Related]

  • 20. Blood testosterone threshold for androgen deficiency symptoms.
    Kelleher S, Conway AJ, Handelsman DJ.
    J Clin Endocrinol Metab; 2004 Aug 20; 89(8):3813-7. PubMed ID: 15292310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.